alum (aluminum hydroxide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for alum (aluminum hydroxide), covering 2014-05-22 to 2014-05-22. Get the full timeline:
Most recent: Clinical Trial Update: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [Phase 2]